IRIS International, Inc.  

(Public, NASDAQ:IRIS)   Watch this stock  
Find more results for IRIS
Oct 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 8.50 - 19.97
Open     -
Vol / Avg. 0.00/312,442.00
Mkt cap 350.96M
P/E 475.71
Div/yield     -
EPS 0.04
Shares     -
Beta 1.24
Inst. own     -

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 3.92% -1.01%
Operating margin 5.27% -3.72%
EBITD margin - -0.26%
Return on average assets 4.26% -1.09%
Return on average equity 5.22% -1.34%
Employees 387 -
CDP Score - -


9172 Eton Avenue, Chatsworth
CHATSWORTH, CA 91311-5874
United States - Map
+1-818-5277000 (Phone)
+1-818-7009661 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


IRIS International, Inc. is a manufacturer of automated in vitro diagnostic systems (IVD), sample processing products and personalized diagnostics tests for use in hospitals and laboratories worldwide. The Company’s IVD products analyze the chemistry and morphology of cells and sediments in a variety of body fluids. It is also a provider of automated urine microscopy systems, with more than 3,600 iQ microscopy analyzers shipped to date in over 50 countries. It is focused on developing, manufacturing and commercializing in vitro diagnostics instruments and consumables for urinalysis, including its flagship iQ analyzers, a family of fully-automated, image-based bench-top analyzers for urine microscopy. Its commercialized products and product pipeline comprise three main categories: morphology, sample processing and personalized medicine.